Gartner, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Gartner, Inc. (IT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $22.10 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2012-11-06
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2012-09-30 was $3.40M, a 100.00% increase year-over-year.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2012-06-30 was $7.20M.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2012-03-31 was $11.50M.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2011-12-31 was $3.90M.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2011 was $39.60M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2012-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $10.60M derived: sum of 2 quarters · filed 2012-11-06 | $22.10M 10-Q · filed 2012-11-06 | $26.00M derived: sum of 4 quarters · filed 2012-11-06 |
| 2012-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $18.70M 10-Q · filed 2012-08-03 | $22.60M derived: sum of 3 quarters · filed 2012-08-03 | $24.30M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $11.50M 10-Q · filed 2012-05-03 | $15.40M derived: sum of 2 quarters · filed 2012-05-03 | $17.10M derived: sum of 3 quarters · filed 2012-05-03 | |
| 2011-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $5.60M derived: sum of 2 quarters · filed 2012-02-23 | $39.60M 10-K · filed 2012-02-23 | |
| 2011-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $35.70M 10-Q · filed 2011-11-01 | ||
| 2011-06-30 | $34.00M 10-Q · filed 2011-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |